Steward Partners Investment Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164K | Sell |
892
-53
| -6% | -$9.77K | ﹤0.01% | 2119 |
|
|
2025
Q4 | $166K | Sell |
945
-17
| -2% | -$2.78K | ﹤0.01% | 2008 |
|
|
2025
Q3 | $135K | Sell |
962
-28
| -3% | -$3.79K | ﹤0.01% | 2068 |
|
|
2025
Q2 | $124K | Sell |
990
-82
| -8% | -$10.2K | ﹤0.01% | 1985 |
|
|
2025
Q1 | $147K | Sell |
1,072
-409
| -28% | -$58.5K | ﹤0.01% | 1799 |
|
|
2024
Q4 | $226K | Sell |
1,481
-691
| -32% | -$117K | ﹤0.01% | 1534 |
|
|
2024
Q3 | $421K | Buy |
2,172
+430
| +25% | +$90K | ﹤0.01% | 1180 |
|
|
2024
Q2 | $404K | Sell |
1,742
-129
| -7% | -$28K | ﹤0.01% | 1150 |
|
|
2024
Q1 | $403K | Buy |
1,871
+71
| +4% | +$16.6K | ﹤0.01% | 1149 |
|
|
2023
Q4 | $466K | Sell |
1,800
-9,400
| -84% | -$2.31M | 0.01% | 1030 |
|
|
2023
Q3 | $2.88M | Buy |
11,200
+9,389
| +518% | +$2.51M | 0.04% | 376 |
|
|
2023
Q2 | $516K | Sell |
1,811
-37
| -2% | -$11K | 0.01% | 924 |
|
|
2023
Q1 | $514K | Sell |
1,848
-157
| -8% | -$43.4K | 0.01% | 917 |
|
|
2022
Q4 | $555K | Buy |
2,005
+63
| +3% | +$17.8K | 0.01% | 878 |
|
|
2022
Q3 | $519K | Buy |
1,942
+14
| +0.7% | +$2.97K | 0.01% | 845 |
|
|
2022
Q2 | $393K | Sell |
1,928
-7
| -0.4% | -$1.43K | 0.01% | 940 |
|
|
2022
Q1 | $408K | Sell |
1,935
-166
| -8% | -$36.1K | 0.01% | 997 |
|
|
2021
Q4 | $504K | Buy |
2,101
+173
| +9% | +$44.5K | 0.01% | 931 |
|
|
2021
Q3 | $546K | Sell |
1,928
-123
| -6% | -$40.3K | 0.01% | 873 |
|
|
2021
Q2 | $710K | Sell |
2,051
-718
| -26% | -$218K | 0.01% | 802 |
|
|
2021
Q1 | $775K | Buy |
2,769
+469
| +20% | +$126K | 0.01% | 733 |
|
|
2020
Q4 | $563K | Sell |
2,300
-83
| -3% | -$21.4K | 0.01% | 724 |
|
|
2020
Q3 | $676K | Buy |
2,383
+394
| +20% | +$110K | 0.02% | 588 |
|
|
2020
Q2 | $532K | Buy |
1,989
+398
| +25% | +$120K | 0.02% | 609 |
|
|
2020
Q1 | $503K | Sell |
1,591
-679
| -30% | -$206K | 0.02% | 560 |
|
|
2019
Q4 | $673K | Sell |
2,270
-151
| -6% | -$41.9K | 0.02% | 557 |
|
|
2019
Q3 | $563K | Buy |
2,421
+301
| +14% | +$70.1K | 0.02% | 550 |
|
|
2019
Q2 | $495K | Sell |
2,120
-741
| -26% | -$171K | 0.02% | 566 |
|
|
2019
Q1 | $676K | Sell |
2,861
-924
| -24% | -$291K | 0.03% | 441 |
|
|
2018
Q4 | $1.14M | Sell |
3,785
-144
| -4% | -$46K | 0.06% | 311 |
|
|
2018
Q3 | $1.39M | Sell |
3,929
-826
| -17% | -$284K | 0.07% | 278 |
|
|
2018
Q2 | $1.38M | Buy |
4,755
+52
| +1% | +$14.6K | 0.08% | 242 |
|
|
2018
Q1 | $1.29M | Buy |
4,703
+542
| +13% | +$168K | 0.09% | 231 |
|
|
2017
Q4 | $1.32M | Buy |
4,161
+1,629
| +64% | +$523K | 0.1% | 201 |
|
|
2017
Q3 | $792K | Buy |
2,532
+1,041
| +70% | +$308K | 0.08% | 216 |
|
|
2017
Q2 | $404K | Buy |
1,491
+489
| +49% | +$129K | 0.05% | 306 |
|
|
2017
Q1 | $273K | Buy |
1,002
+552
| +123% | +$156K | 0.04% | 288 |
|
|
2016
Q4 | $127K | Buy |
+450
| New | +$133K | 0.06% | 225 |
|
Other funds holding BIIB
VCM
VPM
Steward Partners Investment Advisory's BIIB Position: Q1 2026 in Review
Steward Partners Investment Advisory reduced its Biogen (BIIB) stake by 5.6% in Q1 2026, selling an estimated $9.77K and leaving 892 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.
Steward Partners Investment Advisory first reported a position in BIIB in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.88M in Q3 2023. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Steward Partners Investment Advisory held 892 shares of Biogen worth $164K as of Q1 2026.
- Steward Partners Investment Advisory sold 53 Biogen shares in Q1 2026, an estimated $9.77K.
- Biogen made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2119 holding.
- Steward Partners Investment Advisory first reported a position in Biogen in Q4 2016 and has held it in 38 quarters since.
- Steward Partners Investment Advisory's Biogen position peaked at $2.88M in Q3 2023.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.